Biogen, Aduhelm and Medicare RX Model

They make no bones about saying the Part B premium increase is due to the cost of Aduhelm. Yet, CMS has not reached a decision to cover it. Let that sink in. 

Meanwhile, the VA, the EU, and one or several major healthcare provider systems in the US has/have said no based on the sketchy efficacy. 

Of course, if CMS joins the naysayer crowd, the increased premium will be cheerfully refunded....

Oh, and BTW, Aduhelm is by infusion which is why it is theoretically to be covered by PART B which has nothing to do with the Prescription drug program.